Taylor Frigon Capital Management LLC Glaukos Corp Transaction History

Taylor Frigon Capital Management LLC

$199 Million
Q3 2024

A detailed history of Taylor Frigon Capital Management LLC transactions in Glaukos Corp stock. As of the latest transaction made, Taylor Frigon Capital Management LLC holds 28,022 shares of GKOS stock, worth $4.04 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

28,022

Previous 39,676 29.37%

Holding current value

$4.04 Million

Previous $4.7 Million 22.26%

% of portfolio

1.84%

Previous 2.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$113.62 - $135.39 $1.32 Million - $1.58 Million	-11,654 Reduced 29.37%	28,022 $3.65 Million
Q2 2024 Jul 29, 2024	SELL	$89.48 - $118.35 $818,205 - $1.08 Million	-9,144 Reduced 18.73%	39,676 $4.7 Million
Q1 2024 Apr 19, 2024	SELL	$76.4 - $96.33 $37,741 - $47,587	-494 Reduced 1.0%	48,820 $4.6 Million
Q4 2023 Jan 29, 2024	SELL	$59.53 - $85.11 $134,121 - $191,752	-2,253 Reduced 4.37%	49,314 $3.92 Million
Q3 2023 Oct 25, 2023	SELL	$69.23 - $79.09 $86,745 - $99,099	-1,253 Reduced 2.37%	51,567 $3.88 Million
Q2 2023 Jul 28, 2023	SELL	$45.44 - $71.21 $512,017 - $802,394	-11,268 Reduced 17.58%	52,820 $3.76 Million
Q1 2023 Apr 25, 2023	SELL	$43.88 - $52.48 $46,117 - $55,156	-1,051 Reduced 1.61%	64,088 $3.21 Million
Q4 2022 Feb 03, 2023	SELL	$40.82 - $57.75 $120,868 - $170,997	-2,961 Reduced 4.35%	65,139 $2.85 Million
Q3 2022 Nov 04, 2022	SELL	$46.84 - $58.49 $1.31 Million - $1.63 Million	-27,865 Reduced 29.04%	68,100 $3.63 Million
Q2 2022 Aug 04, 2022	SELL	$34.86 - $63.77 $406,711 - $744,004	-11,667 Reduced 10.84%	95,965 $4.36 Million
Q1 2022 Apr 25, 2022	SELL	$44.33 - $57.82 $46,502 - $60,653	-1,049 Reduced 0.97%	107,632 $6.22 Million
Q4 2021 Jan 21, 2022	BUY	$40.27 - $56.99 $8,174 - $11,568	203 Added 0.19%	108,681 $4.83 Million
Q3 2021 Oct 27, 2021	BUY	$47.43 - $84.23 $1.89 Million - $3.35 Million	39,785 Added 57.92%	108,478 $5.23 Million
Q2 2021 Jul 26, 2021	SELL	$73.06 - $97.7 $292,386 - $390,995	-4,002 Reduced 5.51%	68,693 $5.83 Million
Q1 2021 Apr 23, 2021	SELL	$70.43 - $97.42 $83,177 - $115,053	-1,181 Reduced 1.6%	72,695 $6.1 Million
Q4 2020 Jan 22, 2021	SELL	$48.9 - $75.26 $611,592 - $941,276	-12,507 Reduced 14.48%	73,876 $5.56 Million
Q3 2020 Oct 20, 2020	BUY	$37.23 - $50.97 $1.32 Million - $1.81 Million	35,481 Added 69.7%	86,383 $4.28 Million
Q2 2020 Jul 22, 2020	BUY	$28.78 - $46.83 $19,599 - $31,891	681 Added 1.36%	50,902 $1.96 Million
Q1 2020 May 06, 2020	BUY	$25.53 - $70.14 $222,979 - $612,602	8,734 Added 21.05%	50,221 $1.55 Million
Q1 2020 Apr 24, 2020	SELL	$25.53 - $70.14 $5,871 - $16,132	-230 Reduced 0.55%	41,487 $1.28 Million
Q4 2019 Jan 24, 2020	SELL	$54.18 - $65.64 $4,659 - $5,645	-86 Reduced 0.21%	41,717 $2.27 Million
Q3 2019 Nov 01, 2019	SELL	$58.58 - $83.91 $100,464 - $143,905	-1,715 Reduced 3.94%	41,803 $2.61 Million
Q2 2019 Jul 17, 2019	BUY	$63.59 - $78.71 $108,738 - $134,594	1,710 Added 4.09%	43,518 $3.28 Million
Q1 2019 Apr 25, 2019	SELL	$50.75 - $80.54 $659,902 - $1.05 Million	-13,003 Reduced 23.72%	41,808 $3.28 Million
Q4 2018 Feb 07, 2019	SELL	$52.18 - $67.93 $722,223 - $940,219	-13,841 Reduced 20.16%	54,811 $3.08 Million
Q3 2018 Oct 15, 2018	SELL	$38.13 - $68.37 $585,905 - $1.05 Million	-15,366 Reduced 18.29%	68,652 $4.46 Million
Q2 2018 Aug 01, 2018	SELL	$27.62 - $44.51 $47,810 - $77,046	-1,731 Reduced 2.02%	84,018 $3.41 Million
Q1 2018 Apr 23, 2018	BUY	$26.05 - $34.5 $666,671 - $882,924	25,592 Added 42.54%	85,749 $2.64 Million
Q4 2017 Jan 25, 2018	BUY	$24.5 - $36.01 $1.47 Million - $2.17 Million	60,157	60,157 $1.54 Million

Others Institutions Holding GKOS

# of Institutions

340

Shares Held

47.1M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Frigon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Frigon Capital Management LLC with notifications on news.

Account

Taylor Frigon Capital Management LLC Glaukos Corp Transaction History